Fennec Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Fennec Pharmaceuticals Inc. (FENC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents26.6313.2723.7721.1030.3413.6522.78
Cash & Short-Term Investments26.6313.2723.7721.1030.3413.6522.78
Accounts Receivable12.888.811.550.000.000.000.00
Inventory1.062.160.580.000.000.000.00
Other Current Assets0.470.040.061.030.800.010.00
Total Current Assets44.1226.8626.7322.3931.4213.8822.95
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.00
Other Non-Current Assets0.820.010.000.000.000.000.00
Total Non-Current Assets0.820.010.210.030.000.260.00
Total Assets44.9526.8626.9422.4131.4214.1522.95
Current Liabilities
Accounts Payable3.247.534.610.781.572.271.64
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities3.433.752.220.880.780.000.00
Deferred Revenue0.250.000.000.000.000.000.00
Other Current Liabilities3.430.000.000.000.002.271.64
Total Current Liabilities6.927.554.611.652.352.271.64
Non-Current Liabilities
Long-Term Debt19.340.2924.644.990.000.000.00
Other Non-Current Liabilities0.0031.220.260.000.000.000.00
Total Non-Current Liabilities43.9031.5124.904.990.000.000.00
Total Liabilities50.8239.0629.516.642.352.271.64
Stockholders' Equity
Common Stock145.61144.31142.59140.80140.730.000.00
Retained Earnings-219.68-219.25-203.20-179.49-162.14-144.03-131.26
Accumulated Other Comprehensive Income1.241.241.241.241.241.241.24
Additional Paid-in Capital66.9662.0756.8053.2149.2348.2744.93
Shares Outstanding27.5327.0326.3626.010.000.000.00
Total Stockholders' Equity-5.87-11.62-2.5715.7729.0711.8821.31
Total Liabilities & Equity44.9526.8626.9422.4131.4214.1522.95